Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCL8 | P10145 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | XIAP | P98170 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PNMT | P11086 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.33 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18567614 | 1.00 | CXCL8 (0.36) | CXCL8ALOX5POLBSMN1; SMN2TSHR | |
| SCHEMBL3435918 | 1.00 | CXCL8 (0.36) | CXCL8ALOX5POLBSMN1; SMN2TSHR | |
| SCHEMBL3437256 | 1.00 | CXCL8 (0.36) | CXCL8ALOX5POLBSMN1; SMN2TSHR | |
| SCHEMBL15165091 | 0.90 | RIPK1 (0.38) | SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL16067467 | 0.90 | RIPK1 (0.38) | SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL3435921 | 0.84 | CXCL8 (0.35) | CXCL8ALOX5POLBSMN1; SMN2TSHR | |
| SCHEMBL3436161 | 0.84 | CXCL8 (0.35) | CXCL8ALOX5POLBSMN1; SMN2TSHR | |
| SCHEMBL3435596 | 0.84 | CXCL8 (0.35) | CXCL8ALOX5POLBSMN1; SMN2TSHR | |
| SCHEMBL16067624 | 0.83 | CXCL8 (0.36) | CXCL8ALOX5POLBSMN1; SMN2TSHR | |
| SCHEMBL15078589 | 0.83 | CXCL8 (0.36) | CXCL8ALOX5POLBSMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2968211-B1 | PHENYL ALKYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME | BIO PHARM SOLUTIONS CO LTD (KR) | 2021-05-12 | — | — | EP | disclosed |
| US-10525030-B2 | Phenyl carbamate compound and a composition for neuroprotection comprising the same | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2020-01-07 | — | — | US | disclosed |
| US-9956197-B2 | Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-9956197-B2 | Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-9907776-B2 | Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same | BIO-PHARM SOLUTIONS, CO., LTD. (KR) | 2018-03-06 | — | — | US | disclosed |
| US-9907776-B2 | Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same | BIO-PHARM SOLUTIONS, CO., LTD. (KR) | 2018-03-06 | — | — | US | disclosed |
| US-9872847-B2 | Phenyl carbamate compounds for use in preventing or treating a movement disorder | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-01-23 | — | — | US | disclosed |
| US-9872847-B2 | Phenyl carbamate compounds for use in preventing or treating a movement disorder | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-01-23 | — | — | US | disclosed |
| EP-2527314-B1 | Process for preparation of phenyl carbamate derivatives | BIO-PHARM SOLUTIONS CO LTD (KR) | 2017-10-04 | — | — | EP | disclosed |
| EP-2797878-B1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE | BIO-PHARM SOLUTIONS CO LTD (KR) | 2017-08-16 | — | — | EP | disclosed |
| US-20130165408-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-06-27 | — | — | US | disclosed |
| US-20130165410-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-06-27 | — | — | US | disclosed |
| US-20130165408-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-06-27 | — | — | US | disclosed |
| US-20130165409-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-06-27 | — | — | US | disclosed |
| US-20130005801-A1 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-01-03 | — | — | US | disclosed |
| US-20130005801-A1 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-01-03 | — | — | US | disclosed |
| US-20120184762-A1 | PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2012-07-19 | — | — | US | disclosed |
| US-20120184762-A1 | PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2012-07-19 | — | — | US | disclosed |
| WO-2012096458-A2 | PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2012-07-19 | — | — | WO | disclosed |
| WO-2012002773-A2 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165408-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY | CHAT, BCHE, GABBR1 | CXCL8 4250/4885ALOX5 806/4885POLB 3802/4885 |
| US-20130165409-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN | ACHE, HDAC3, TRPV1 | CXCL8 937/4885ALOX5 1192/4885POLB 4385/4885 |
| US-20130005801-A1 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME | CPT1B, MYLK, PYGM | CXCL8 4711/4885ALOX5 365/4885POLB 2586/4885 |
| US-10525030-B2 | Phenyl carbamate compound and a composition for neuroprotection comprising the same | CHAT, BAX, CASP3 | CXCL8 3198/4885ALOX5 709/4885POLB 4403/4885 |
| US-20130165410-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE | CPS1, PROC, DPP7 | CXCL8 2652/4885ALOX5 808/4885POLB 4247/4885 |
| US-20120184762-A1 | PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES | CPS1, BCHE, ACHE | CXCL8 4740/4885ALOX5 2828/4885POLB 1518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.